Literature DB >> 12194911

Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR.

Werner Koch1, Wolfgang Latz, Marianne Eichinger, Ariel Roguin, Andrew P Levy, Albert Schömig, Adnan Kastrati.   

Abstract

BACKGROUND: A genetically defined molecular heterogeneity of haptoglobin, characterized by the major phenotypic forms Hp 1-1, Hp 2-1, and Hp 2-2, has been associated with distinct clinical manifestations. To enable the use of DNA samples for the study of this polymorphism, we established a haptoglobin genotyping method based on PCR.
METHODS: Taking advantage of the selectivity of PCR, we amplified DNA segments specifically representing haptoglobin alleles Hp 1 and Hp 2 from genomic DNA. The products were analyzed by agarose gel electrophoresis. Haptoglobin phenotyping of plasma samples was performed by polyacrylamide gel electrophoresis and peroxidase staining.
RESULTS: Exploiting the known size difference between Hp 1 and Hp 2, we amplified allele-specific DNA molecules with one pair of oligonucleotide primers. As an alternative, we used separate primer pairs to generate amplification products indicative of alleles Hp 1 and Hp 2. Because of the primer design, genotype determination was not compromised by sequence variations specifying haptoglobin allele subtypes S and F. For the same reason, the sequence similarity between the haptoglobin gene and the haptoglobin-related gene did not interfere with the accuracy of genotyping. Analysis with restriction enzymes demonstrated the authenticity of the allele-specific DNA products. Haptoglobin DNA genotyping and protein phenotyping, performed in parallel, yielded fully corresponding results. In a group of 249 individuals, the haptoglobin genotype distribution was as follows: 14.5% Hp 1-1, 48.2% Hp 2-1, and 37.3% Hp 2-2.
CONCLUSION: The new method can be used for genotyping of a common haptoglobin polymorphism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12194911

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  66 in total

1.  Haptoglobin phenotype in women with preeclampsia.

Authors:  Rami N Sammour; Farid M Nakhoul; Andrew P Levy; Rachel Miller-Lotan; Nakhoul Nakhoul; Hoda R Awad; Ron Gonen; Gonen Ohel
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Haptoglobin 2-2 genotype is associated with increased risk of type 2 diabetes mellitus in northern Chinese.

Authors:  Xiaohong Shi; Liang Sun; Li Wang; Feng Jin; Junfeng Sun; Xiaoquan Zhu; Lei Tang; Yanchun Qu; Ze Yang
Journal:  Genet Test Mol Biomarkers       Date:  2012-02-02

3.  The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype.

Authors:  Leah E Cahill; Majken K Jensen; Stephanie E Chiuve; Hadar Shalom; Jennifer K Pai; Alan J Flint; Kenneth J Mukamal; Kathryn M Rexrode; Andrew P Levy; Eric B Rimm
Journal:  J Am Coll Cardiol       Date:  2015-10-20       Impact factor: 24.094

4.  Haptoglobin genotype and functional outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Ellen Kantor; Hülya Bayır; Dianxu Ren; J Javier Provencio; Laura Watkins; Elizabeth Crago; Michael B Horowitz; Robert E Ferrell; Yvette P Conley; Sheila A Alexander
Journal:  J Neurosurg       Date:  2013-11-29       Impact factor: 5.115

5.  Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome.

Authors:  Laura M L Carvalho; Cláudia N Ferreira; Daisy K D de Oliveira; Kathryna F Rodrigues; Rita C F Duarte; Márcia F A Teixeira; Luana B Xavier; Ana Lúcia Candido; Fernando M Reis; Ieda F O Silva; Fernanda M F Campos; Karina B Gomes
Journal:  J Assist Reprod Genet       Date:  2017-09-13       Impact factor: 3.412

6.  Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.

Authors:  Joseph McGuirk; Gang Hao; Weijian Hou; Sunil Abhyankar; Casey Williams; Weisi Yan; Jianda Yuan; Xiuqin Guan; Robert Belt; Shaun Dejarnette; Jeffery Wieman; Ying Yan
Journal:  J Hematol Oncol       Date:  2009-04-20       Impact factor: 17.388

7.  Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children.

Authors:  Mathilde Savy; Branwen J Hennig; Conor P Doherty; Anthony J Fulford; Robin Bailey; Martin J Holland; Giorgio Sirugo; Kirk A Rockett; Dominic P Kwiatkowski; Andrew M Prentice; Sharon E Cox
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

8.  Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.

Authors:  Tina Costacou; Aaron M Secrest; Robert E Ferrell; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2014-07-03       Impact factor: 3.291

9.  Haptoglobin genotype and renal function decline in type 1 diabetes.

Authors:  Tina Costacou; Robert E Ferrell; Demetrius Ellis; Trevor J Orchard
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

10.  HFE-Related Hemochromatosis: The Haptoglobin 2-2 Type Has a Significant but Limited Influence on Phenotypic Expression of the Predominant p.C282Y Homozygous Genotype.

Authors:  Gérald Le Gac; Chandran Ka; Isabelle Gourlaouen; Laurence Bryckaert; Anne-Yvonne Mercier; Brigitte Chanu; Virginie Scotet; Claude Férec
Journal:  Adv Hematol       Date:  2009-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.